Endometriosis After Surgery: Why Lesions Can Return and How Repeat Treatment Is Planned

Two years after her laparoscopy, she notices it on a Tuesday: the same low, dragging ache on the left side, arriving three days before her period, exactly where it used to. The first thought is not medical. It is a kind of grief. She did the hard thing, took the weeks off, kept the follow-up appointments, and now the pain seems to be back as if nothing happened.

This is one of the most common and least discussed experiences in gynecology. Endometriosis recurrence after surgery is not a sign that someone did something wrong, and it is not proof that the operation failed. It reflects how the condition behaves. Surgery clears what a surgeon can see and reach on that day; it does not switch off the biology that produced the lesions in the first place.

What follows is an honest map of why lesions return, how often, what the numbers actually measure, and how a second round of treatment is usually thought through.

What does endometriosis recurrence after surgery actually mean?

Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it, most often on the ovaries, the ligaments behind the uterus, and the lining of the pelvis. When people talk about endometriosis recurrence after surgery, they are usually describing one of three different situations, and the distinction shapes everything that comes next.

The first is true recurrence: lesions were fully removed, healing was complete, and new deposits developed later. The second is persistence: disease was left behind, either because it was too deep, too close to the bowel or ureter to remove safely, or simply not visible at the time. The third, and the most common in daily practice, is recurrence of symptoms without any proven return of lesions. Pain comes back, but imaging and sometimes even a second look inside the pelvis show no new disease.

Researchers use different yardsticks. Some studies count anyone whose pain returns. Others require an ovarian cyst to reappear on ultrasound. The strictest require histologic confirmation, meaning a pathologist has examined tissue from a repeat operation under a microscope and found endometriosis. The Cleveland Clinic and Mayo Clinic both note that laparoscopy remains the only way to confirm the diagnosis with certainty, which is why symptom-based recurrence figures run higher than tissue-confirmed ones.

Why does this matter to a person sitting in a clinic? Because the plan for persistent deep disease is different from the plan for new small lesions, and both differ from the plan for pain that has another source. Sorting out which situation applies is the real first step, before anyone discusses another operation.

What is the recurrence rate of endometriosis after surgery?

The most widely cited synthesis comes from a systematic review of long-term follow-up studies published in Human Reproduction Update. Pooling data across different surgical approaches and definitions, it estimated recurrence at about 21.5 percent within two years of surgery, rising to roughly 40 to 50 percent by five years. Those figures have been repeated in patient information for over a decade, and they remain the best available summary.

They also deserve some unpacking. The review found that recurrence rates depend heavily on how recurrence was defined and how long people were followed. Studies tracking symptom return reported the highest rates. Studies requiring a cyst to reappear on ultrasound sat in the middle. Studies demanding tissue proof from a second operation reported the lowest, partly because many people with returning pain never have a second surgery.

Ovarian endometriomas, the chocolate-colored cysts that form when endometriosis grows within the ovary, have their own recurrence pattern. They are easier to track because ultrasound can see them, and the same review noted that how the cyst was removed influenced how often it came back.

Two cautions apply. First, these are group averages drawn from studies with different populations, surgeons, and follow-up. They do not predict what will happen to one individual. Second, the studies were conducted over a period when surgical technique and post-operative hormone therapy varied widely, so the range is broad for a reason.

The honest summary: a return of symptoms within five years is common enough that it should be part of the conversation before the first operation, not a surprise afterward.

Why lesions can return after they were removed

Surgery treats what exists. It does not change what caused it. The Mayo Clinic describes several proposed origins for endometriosis, and none of them is fixed by removing lesions.

The leading explanation is retrograde menstruation, in which menstrual blood containing lining cells flows backward through the fallopian tubes into the pelvis instead of leaving the body. Most people experience some of this every cycle; in those prone to endometriosis, the cells implant and grow. As long as periods continue, the process continues. Another theory holds that cells lining the abdomen can transform into endometrium-like tissue under hormonal or inflammatory signals. A third points to embryonic cells that remained in the pelvis from before birth. A fourth involves spread through blood or lymph vessels, which would help explain rare lesions in the lungs or diaphragm.

Whatever the route, the tissue responds to estrogen. The ovaries keep producing it in cycles after surgery, and the deposits, wherever they seed, keep responding.

Microscopic disease adds another layer. The Cleveland Clinic notes that lesions vary in color and size, and some are tiny or hidden beneath what looks like normal peritoneum. A surgeon removes everything visible, but deposits a fraction of a millimeter across can escape notice and grow over the following years. That is not persistence in the usual sense; it is disease that was present but below the threshold of sight.

Put together, recurrence is less a failure of the operation than a predictable consequence of a chronic, hormone-responsive condition treated with a one-time intervention. That framing is why most guidance now pairs surgery with a longer-term plan rather than treating the operation as an endpoint.

Who is more likely to see endometriosis come back?

Several patterns emerge across follow-up studies, though none predicts an individual outcome and they often overlap.

Age at first surgery is one. The Human Reproduction Update review found that people operated on at a younger age tended to have higher recurrence rates, which makes biological sense: more years of ovarian cycling lie ahead, and more time means more opportunity for new implants.

Extent of disease at the first operation is another. Higher-stage disease, deep infiltrating lesions (deposits that penetrate more than a few millimeters into tissue such as the bowel wall, bladder, or the ligaments behind the uterus), and ovarian endometriomas are all associated with higher rates of symptom return. Part of this is persistence rather than true recurrence, because deep disease is harder to remove completely without risking injury to nearby organs.

Completeness of removal is a third factor, and the least visible from the outside. A surgeon who stops short of a lesion near the ureter, the tube carrying urine from kidney to bladder, has made a reasonable safety decision, but the residual tissue can grow.

Whether hormone therapy was used after surgery matters too. The same review reported that post-operative hormonal suppression reduced recurrence, particularly for endometriomas, and that the benefit was tied to continued use.

Coexisting adenomyosis, in which similar tissue grows into the muscular wall of the uterus itself, is increasingly recognized as a reason pain persists after pelvic lesions are removed, since a laparoscopy for endometriosis does not treat the uterine wall.

None of these factors means recurrence is inevitable. They are simply the variables a care team weighs when deciding how closely to follow someone and whether to recommend suppression afterward.

Does excision or ablation change the chance of recurrence?

Two surgical techniques dominate. Excision means cutting a lesion out entirely, removing the deposit and a margin of tissue beneath it. Ablation means destroying the surface of a lesion with heat, laser, or electrical energy without removing it. Both are performed through laparoscopy, keyhole surgery using a camera and thin instruments through small abdominal incisions.

Excision has two practical advantages. It allows the removed tissue to be sent for histology, confirming the diagnosis and ruling out other findings. It also reaches beneath the surface, which matters for deep infiltrating disease, where ablation may char the top of a lesion and leave the bulk of it in place. Many surgeons regard excision as preferable for deep disease for this reason, though the NHS and Mayo Clinic frame the choice as one the surgeon makes based on location, depth, and safety rather than a rule.

For superficial peritoneal lesions, the evidence comparing the two techniques for pain outcomes is limited and mixed, and honest summaries acknowledge that a clear winner has not been established in high-quality trials.

Ovarian endometriomas are the exception where technique has been studied more closely. The Human Reproduction Update review reported that removing the cyst wall (cystectomy) was associated with lower recurrence than draining and ablating the cyst lining. The trade-off is ovarian reserve: stripping the cyst wall can remove some healthy ovarian tissue along with it, which is a real consideration for anyone planning pregnancy.

The practical takeaway is that the question to ask a surgeon is not simply which technique they use, but how they decide, and what they plan to do if a lesion sits somewhere that makes complete removal risky.

Endometriosis pain after surgery: is it always recurrence?

It is not, and assuming so leads some people toward a second or third operation that does not help. Several other pain generators are common after pelvic surgery, and they can feel remarkably like the original disease.

Adhesions are bands of scar tissue that form between organs as the body heals. Any pelvic operation can produce them, and they can tether the ovary, bowel, or uterus in ways that pull and ache, especially with movement or during a bowel movement. Imaging often cannot see them. They are treatable surgically but also tend to re-form, which is one reason surgeons hesitate to operate repeatedly for adhesions alone.

Central sensitization is a change in how the nervous system processes pain after months or years of pelvic inflammation. The spinal cord and brain begin amplifying signals, so ordinary sensations register as painful and the pain outlasts the tissue that caused it. This is not imaginary and not psychological in the dismissive sense; it is a measurable shift in nerve behavior. Removing lesions does not reset it.

Pelvic floor muscle spasm is a frequent companion. Muscles that have guarded a painful pelvis for years can stay tight, causing deep aching, pain with intercourse, and bladder or bowel urgency.

Adenomyosis, irritable bowel syndrome, and bladder pain syndrome each overlap with endometriosis symptoms and are not addressed by lesion removal.

The point is not to discourage anyone from reporting pain. It is the opposite. Reporting it early, with specifics about timing, location, and triggers, gives the care team a chance to sort out which of these is at work, because the treatments differ substantially and repeat surgery is only the right answer for some of them.

How doctors check whether the disease has returned

The process usually starts with a careful history, and the details carry more weight than people expect. Pain that follows the menstrual cycle points differently from pain that is constant. Pain with deep intercourse, painful bowel movements during periods, or blood in urine at menstruation each hints at particular locations. A history that has changed since the first surgery, for example new bowel symptoms, prompts a look at areas not previously involved.

A pelvic examination follows. A clinician may feel nodules in the ligaments behind the uterus, tenderness in specific spots, or an ovary that is enlarged or fixed in place. The Mayo Clinic notes that small lesions cannot be felt and that a normal exam does not rule out recurrence.

Transvaginal ultrasound is the first-line imaging test. It is good at detecting endometriomas, and in experienced hands it can identify deep lesions on the bowel or bladder. It cannot see superficial peritoneal deposits, which are the most common type. Magnetic resonance imaging, MRI, maps deep disease in more detail and is often used when bowel or urinary tract involvement is suspected or when surgery is being planned.

Blood tests do not diagnose recurrence. A marker called CA-125 can be raised in endometriosis but also in many other conditions, and a normal result does not exclude disease.

Laparoscopy remains the definitive test, but it is also an operation, so it is rarely undertaken purely to look. When a second surgery happens, the surgeon compares findings with the notes and photographs from the first, which is why keeping copies of operative reports is genuinely useful.

Often the conclusion is probabilistic rather than certain: symptoms and imaging together make recurrence likely or unlikely, and the plan proceeds on that basis.

How hormone therapy after surgery works to lower the chance of return

Because endometriosis responds to estrogen and grows in step with the menstrual cycle, the logic of post-operative hormone therapy is to quiet that cycle. Fewer or no periods means less retrograde menstruation, less cyclical stimulation of any remaining microscopic deposits, and less inflammation. The NHS describes these medicines as limiting or stopping estrogen production, which slows the growth of endometriosis tissue.

Several classes are used, and a prescribing clinician chooses among them based on side-effect profile, other health conditions, and whether pregnancy is planned. Combined hormonal contraceptives suppress ovulation and thin the lining. Progestin-only options, which include tablets, injections, implants, and a hormone-releasing intrauterine device placed inside the uterus, act similarly and are often chosen when estrogen is unsuitable. Gonadotropin-releasing hormone (GnRH) agonists and antagonists switch off the signal from the brain that tells the ovaries to produce estrogen, creating a temporary menopause-like state; these are usually paired with low-level add-back hormones to protect bone and limit hot flashes, and their duration of use is limited for that reason.

The evidence summarized in the Human Reproduction Update review points to a consistent pattern: suppression after surgery reduces recurrence, especially of endometriomas, but the protection lasts while the treatment continues. Symptoms commonly return within months of stopping, which is why many clinicians frame this as long-term management rather than a short course.

None of this applies to someone trying to conceive right away, since all of these approaches prevent pregnancy. For that group, the discussion shifts toward fertility timing and whether a window of trying should come before suppression starts.

Whether to use any of these, which one, and for how long are decisions for the prescribing clinician with the person in front of them.

Who is usually offered repeat endometriosis surgery, and who is asked to wait

There is no fixed number of operations a person can have. The question surgeons actually weigh is whether another operation is likely to help more than it harms, and that calculus shifts with each procedure.

Repeat surgery is more often offered when imaging shows a specific target: a growing or symptomatic endometrioma, a deep lesion on the bowel or bladder with matching symptoms, a nodule that could be compressing the ureter, or a cyst whose appearance on ultrasound is uncertain enough to warrant removal for diagnosis. It is also considered when pain remains disabling despite a fair trial of hormonal and non-hormonal management, and when someone is planning fertility treatment and a surgeon believes removing disease would help.

People are more often asked to wait, or steered toward other approaches first, when pain has returned but imaging and examination are normal, when the last operation was recent and healing may still be underway, when pain features suggest central sensitization or pelvic floor involvement, or when hormonal suppression has not yet been tried. The NHS notes that surgery carries risks and that symptoms can return even after successful operations, which is why medical options are frequently the first response to recurrence.

Each additional laparoscopy adds cumulative considerations: more adhesions, greater technical difficulty, and, for ovarian surgery, further loss of ovarian reserve. Surgeons also weigh the diminishing returns of operating on someone whose pain has not responded to previous complete excisions.

Asking to wait is not dismissal. It usually reflects a judgment that another approach has a better chance of helping, or that operating now would carry more risk than benefit. The decision belongs to the treating team together with the person living with the condition, and it can be revisited as circumstances change.

Repeat surgery vs other options: how the choices compare

When symptoms return, the options are rarely either/or. Many people end up with a combination, sequenced over time. The table below summarizes the main approaches in neutral terms; suitability always depends on the individual picture.

Approach	What it does	Often considered when	Main trade-offs
Hormonal suppression	Quiets the menstrual cycle and estrogen stimulation of remaining deposits	Symptoms return; no immediate pregnancy plans; imaging shows no urgent target	Side effects vary by class; protection lasts only while treatment continues; prevents conception
Repeat laparoscopic excision	Removes new or residual lesions and adhesions; confirms diagnosis by histology	Imaging shows a defined target; deep disease affecting bowel, bladder, or ureter; fertility planning	Operative risks; new adhesions; possible loss of ovarian reserve; recurrence remains possible
Hysterectomy, ovaries kept	Removes the uterus and any adenomyosis; ends periods	Adenomyosis is a major pain source; family complete	Endometriosis outside the uterus can persist; ovaries still cycle
Hysterectomy with ovary removal	Removes uterus and ovaries, sharply lowering estrogen	Severe disease, family complete, other options exhausted	Surgical menopause; bone and heart health considerations; residual deposits can still cause symptoms
Pain-focused care	Addresses nerve sensitization, pelvic floor spasm, bowel and bladder overlap	Pain persists without imaging findings; multiple prior surgeries	Requires time and often several disciplines; does not remove lesions

A reasonable pattern in guidance from the NHS and Mayo Clinic is to try the least invasive effective option first, escalate when it fails, and reserve organ-removing surgery for situations where other routes have been exhausted and childbearing is complete. The strongest opinion the evidence supports is this: repeat surgery works best when there is something specific to remove, and least well when it is done in the hope of finding an explanation for pain.

Hysterectomy for endometriosis: what it does and does not fix

For decades, removing the uterus, with or without the ovaries, was treated as the final answer to endometriosis. The Mayo Clinic now describes a shift away from that view, and the reasoning is worth understanding before anyone considers it.

A hysterectomy removes the uterus. Endometriosis, by definition, is tissue outside the uterus. Removing the organ ends periods and therefore ends retrograde menstruation, and it eliminates adenomyosis entirely because adenomyosis lives in the uterine wall. It does not remove deposits on the bowel, bladder, ligaments, or pelvic lining. If those are left behind and the ovaries remain, they continue to receive estrogen and can continue to cause symptoms.

Removing the ovaries as well drops estrogen sharply and starves most remaining deposits. That is why the older approach included it. The cost is surgical menopause, with implications for bone density, cardiovascular health, sleep, mood, and sexual function that arrive at once rather than gradually. Some people still have symptoms afterward, either from residual deep lesions or from the non-lesion pain sources described earlier. Hormone replacement after ovary removal is itself a nuanced decision when endometriosis deposits may remain.

Many people searching for information about this want to know whether the swollen abdomen sometimes called “endo belly” or “adenomyosis belly” resolves after a hysterectomy. The Mayo Clinic describes hysterectomy as the definitive treatment for adenomyosis, so bloating driven by an enlarged, inflamed uterus is expected to settle once the uterus is gone. Bloating driven by bowel involvement, adhesions, or irritable bowel overlap is a different matter and may not change.

The decision sits with the person and their surgical team, weighed against age, fertility plans, the pattern of disease, and what has already been tried.

What the days and weeks after repeat surgery usually look like

Recovery after a second or third laparoscopy follows the same broad shape as the first, with a few differences worth knowing.

The NHS describes laparoscopic recovery as varying with what was done: a diagnostic look usually means a return to normal activities within days, while extensive excision or bowel work takes considerably longer. Most people go home the same day or after one night. Shoulder-tip pain from the gas used to inflate the abdomen is common in the first couple of days and eases as the gas is absorbed. Light vaginal bleeding or spotting can occur, and small incisions are tender.

Repeat operations tend to involve more adhesion work, and dissection around scar tissue can mean a little more soreness and a slower first week. Bowel function may take a few days to settle, especially if the bowel was handled or if a segment was treated.

The hardest part of this window is often interpretive rather than physical. Healing pain and disease pain overlap in the early weeks, and it is normal to feel a spike of anxiety with every twinge. Clinicians generally advise judging the outcome over months, not days, because inflammation from surgery itself has to resolve before the true picture emerges.

When hormonal suppression is part of the plan, it is frequently started soon after surgery so that the pelvis is quiet while it heals; the exact timing is set by the prescribing clinician. A follow-up visit is usually arranged to review histology results, discuss what was found and removed, and confirm the longer-term plan.

Gentle walking from the first day, gradual return to work as energy allows, and a low threshold for calling with concerns are the practical anchors of these weeks.

What people often get wrong about endometriosis coming back

“If pain returns, the surgeon must have missed something.” Sometimes disease is left behind for safety reasons, but new lesions can also arise from tissue that was microscopic at the time, and returning pain frequently has a non-lesion source. Recurrence is a property of the condition, not a verdict on the surgeon.

“Pregnancy will get rid of it.” Pregnancy often suspends symptoms because periods stop and hormone patterns change. The Cleveland Clinic and NHS both note that symptoms commonly return after delivery and breastfeeding. Pregnancy is a life decision, not a treatment.

“A hysterectomy ends endometriosis for good.” It ends adenomyosis and periods. Deposits outside the uterus can persist, particularly if the ovaries remain, and even after ovary removal some people continue to have symptoms.

“More surgery is always better than medication.” Surgery has clear advantages when there is a defined target. When imaging is normal and pain persists, the evidence for another operation is weak, and each procedure adds adhesion and ovarian-reserve considerations.

“Menopause always ends it.” Natural menopause lowers estrogen and quiets most disease, but residual lesions can occasionally remain active, and pain from sensitized nerves or scar tissue does not depend on hormones.

“Recurrence means the disease is getting worse.” Recurrence is common and does not by itself indicate progression to a more severe form. Many people cycle through periods of control and flare over years.

“Hormone therapy is only for people who want contraception.” Its role after surgery is to suppress the cycle that feeds the disease. Contraception is a consequence, not the purpose, and that distinction matters for anyone weighing it.

Questions to ask your care team

Bringing a short list to the appointment shifts the conversation from reassurance toward a shared plan. Nobody needs to ask all of these; choose the ones that fit the moment.

• Based on my symptoms and imaging, do you think this is new disease, disease left from last time, or pain from another source such as adhesions or nerve sensitization?
• What did the last operation find and remove, and was anything deliberately left behind? May I have a copy of the operative report and photographs?
• Would an ultrasound with a specialist in endometriosis imaging, or an MRI, change the plan?
• If you are recommending hormonal suppression, how does the option you have in mind work, what side effects should I watch for, and how will we judge whether it is helping?
• If you are recommending surgery, what specifically would you aim to remove, and what would you do if a lesion sits close to the bowel or ureter?
• How would another operation affect my ovarian reserve, and should I consider fertility preservation counseling first?
• Do you think adenomyosis or pelvic floor muscle spasm is contributing, and who would assess that?
• Are there non-surgical, non-hormonal approaches such as pelvic physical therapy or pain-specialist input that should run alongside whatever we choose?
• How long should I give the current plan before we reconsider?
• Which symptoms should prompt me to call before my next scheduled visit?

A team that welcomes these questions is one that will also welcome hearing when a plan is not working. The most useful outcome of the visit is a clear agreement on what is being tried, why, and what the next decision point looks like.

When to call your doctor

Most returning endometriosis symptoms are not emergencies, and the right response is to book a routine appointment and describe what has changed. A few situations call for prompt, same-day contact with the care team or emergency services, whether or not a recent operation is involved.

• Sudden, severe, one-sided pelvic pain, especially with nausea, faintness, or a racing heart. An endometrioma can rupture or an ovary can twist on its blood supply, and both need urgent assessment.
• Fever, chills, or spreading redness, warmth, or discharge at an incision in the weeks after surgery.
• Heavy vaginal bleeding soaking through pads hourly, or bleeding that is much heavier than a usual period after a recent procedure.
• Inability to pass urine, or pain in the flank with fever, which can indicate the ureter is blocked or a kidney is affected.
• Severe abdominal swelling with vomiting and no bowel movements, which can signal a bowel obstruction from adhesions or deep disease.
• Calf pain, swelling, chest pain, or sudden breathlessness after surgery, which can indicate a blood clot.
• A positive pregnancy test alongside pelvic pain or bleeding, since endometriosis raises the chance of pregnancy outside the uterus.

Outside these red flags, changes worth a non-urgent call include a steady increase in cyclical pain, new pain with bowel movements or urination during periods, new pain with intercourse, or side effects from hormone therapy that make it hard to continue. Clinicians would rather hear about a pattern early, when adjusting a plan is straightforward, than months later.

Whatever the symptom, the decision about what it means and what to do next rests with the treating team, who know the history and can examine you. This article can help frame the conversation; it cannot replace it.

Frequently asked questions

What is the recurrence rate of endometriosis after surgery?

Pooled data summarized in Human Reproduction Update put recurrence at roughly 21.5 percent within two years and 40 to 50 percent by five years. The range is wide because studies define recurrence differently: some count returning pain, others a cyst on ultrasound, and the strictest require tissue confirmation at a second operation. These are group averages and do not predict any one person’s course.

How many times can you get endometriosis surgery?

There is no set limit. Surgeons weigh each additional operation against cumulative adhesions, technical difficulty, and possible loss of ovarian reserve. Repeat surgery is most often recommended when imaging shows a defined target such as an endometrioma or deep lesion. When imaging is normal and pain persists, hormonal and pain-focused approaches are usually tried first, and the decision rests with the treating team.

Why does endometriosis pain after surgery come back so soon for some people?

Early return of pain often reflects disease that could not be safely removed, microscopic deposits too small to see, or a pain source other than lesions, such as adhesions or pelvic floor spasm. Ongoing ovarian cycling continues to stimulate any remaining tissue. Clinicians usually judge the surgical outcome over months rather than weeks, because inflammation from the operation itself must settle first.

Is hysterectomy for endometriosis a permanent fix?

Not reliably. A hysterectomy removes the uterus and ends adenomyosis and periods, but endometriosis is tissue outside the uterus and can persist, particularly if the ovaries remain. Removing the ovaries lowers estrogen sharply and reduces symptoms for many people, at the cost of surgical menopause. The Mayo Clinic notes that experts have moved away from viewing hysterectomy as the definitive treatment.

Does adenomyosis belly go away after a hysterectomy?

Bloating and swelling caused by an enlarged, inflamed uterus are expected to resolve, because hysterectomy removes the organ where adenomyosis lives and the Mayo Clinic describes it as the definitive treatment for that condition. Abdominal distension driven by bowel endometriosis, adhesions, or irritable bowel overlap is a separate issue and may not change, which is why the source of swelling is assessed beforehand.

What color is associated with endometriosis awareness?

Yellow is the awareness color for endometriosis, and the yellow ribbon is used by advocacy groups worldwide to mark the condition. It was adopted to make a long-underrecognized disease more visible and to encourage open discussion of symptoms that were historically dismissed. Awareness efforts often emphasize that diagnosis is frequently delayed by years and that recurrence after treatment is common.

Does hormone therapy after surgery really lower the endometriosis recurrence rate?

Evidence summarized in Human Reproduction Update indicates that post-operative hormonal suppression reduces recurrence, with the clearest effect for ovarian endometriomas. The benefit is tied to continued use; symptoms frequently return within months of stopping. Options include combined hormonal contraceptives, progestins including a hormone-releasing intrauterine device, and GnRH-based medicines, and the choice and duration are decided by the prescribing clinician.

Can an ultrasound tell if endometriosis has come back?

Partly. Transvaginal ultrasound reliably detects ovarian endometriomas and, in experienced hands, deep lesions on the bowel or bladder. It cannot see superficial peritoneal deposits, which are the most common type, so a normal scan does not rule out recurrence. MRI adds detail for deep disease. Laparoscopy remains the only way to confirm the diagnosis with certainty, according to the Mayo Clinic and Cleveland Clinic.

Is excision or ablation better for preventing recurrence?

For ovarian endometriomas, removing the cyst wall has been associated with lower recurrence than draining and ablating it, though it may cost some ovarian reserve. For deep infiltrating disease, excision reaches below the surface where ablation may not. For superficial lesions, high-quality comparisons are limited and no clear winner has been established. The surgeon’s judgment about location and safety usually guides the choice.

Will menopause stop endometriosis from recurring?

Natural menopause lowers estrogen and quiets most disease, and many people notice substantial relief. Residual deposits can occasionally remain active, and pain from nerve sensitization or scar tissue does not depend on hormones, so symptoms are not guaranteed to disappear. Decisions about hormone replacement after menopause in someone with a history of endometriosis are individualized with the treating clinician.

References

• Endometriosis: Treatment (NHS)
• Laparoscopy (keyhole surgery): Recovery (NHS)
• Endometriosis (Cleveland Clinic)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.